Pharmacielo Ltd

Healthcare CA PCLO

0.075CAD
0.005(7.14%)

Last update at 2026-06-24T19:34:00Z

Day Range

0.070.07

LowHigh

52 Week Range

0.040.17

LowHigh

Fundamentals

Previous Close 0.07
Market Cap10.34M
Volume5000
P/E Ratio-
Dividend Yield-%
EBITDA-2.61036M
Revenue TTM1.75M
Revenue Per Share TTM0.009
Gross Profit TTM -0.30934M
Diluted EPS TTM-0.05

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Income before tax	-9.14148M	-16.29763M	-14.51635M	-26.62969M	-43.75581M
Minority interest	-	-	-	-	-
Net income	-9.14148M	-16.29763M	-14.51635M	-26.62969M	-43.75581M
Selling general administrative	5.42M	8.31M	11.48M	19.15M	32.60M
Selling and marketing expenses	-	-	-	-	-
Gross profit	0.73M	-1.36884M	0.83M	-4.30837M	-6.63581M
Reconciled depreciation	1.27M	1.41M	1.58M	1.26M	1.57M
Ebit	-	-	-	-25.05717M	-32.85137M
Ebitda	-	-	-11.40118M	-24.74980M	-41.91661M
Depreciation and amortization	-	-	-	-	-
Non operating income net other	-	-	-	-	-
Operating income	-4.90208M	-10.04260M	-11.43438M	-25.19380M	-43.41846M
Other operating expenses	-	-	-	-	0.02M
Interest expense	3.27M	2.69M	1.54M	0.56M	0.27M
Tax provision	-	-	-	-	-
Interest income	0.00001M	0.00018M	0.00183M	0.00237M	0.07M
Net interest income	-3.44381M	-2.86438M	-1.59288M	-0.55892M	-0.20715M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	-	-	-
Total revenue	3.48M	1.54M	5.31M	1.94M	2.65M
Total operating expenses	8.38M	11.58M	16.74M	27.14M	46.07M
Cost of revenue	2.75M	2.91M	4.48M	6.25M	9.29M
Total other income expense net	-0.79558M	-3.39065M	-1.48910M	-0.87697M	-0.13020M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-9.14148M	-16.29763M	-14.51635M	-26.62969M	-43.75581M
Net income applicable to common shares	-	-	-	-26.62969M	-43.75581M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Total assets	18.39M	22.29M	25.12M	35.96M	44.02M
Intangible assets	-	-	-	-	0.12M
Earning assets	-	-	-	-	-
Other current assets	-	-	-	-	-
Total liab	25.91M	23.97M	18.72M	16.63M	17.78M
Total stockholder equity	-7.51613M	-1.67963M	6.39M	19.33M	26.25M
Deferred long term liab	-	-	-	-	-
Other current liab	-	-	-	-	-
Common stock	-	-	-	156.34M	138.08M
Capital stock	167.01M	165.98M	161.71M	156.34M	138.08M
Retained earnings	-207.85349M	-198.71201M	-182.41438M	-167.89802M	-141.26833M
Other liab	-	-	-	0.36M	1.49M
Good will	-	-	-	-	0.00000M
Other assets	-	-	-	-	-
Cash	0.15M	0.06M	0.17M	5.34M	8.86M
Cash and equivalents	-	-	-	-	-
Total current liabilities	21.23M	21.42M	6.95M	8.07M	12.06M
Current deferred revenue	-	-	-	-	-
Net debt	20.38M	18.21M	12.11M	1.88M	-
Short term debt	-	-	-	-	-
Short long term debt	15.85M	15.71M	0.55M	0.08M	0.09M
Short long term debt total	-	-	-	-	-
Other stockholder equity	-	-	-	30.89M	29.43M
Property plant equipment	-	-	-	26.12M	30.82M
Total current assets	2.44M	3.33M	4.02M	9.20M	12.52M
Long term investments	0.23M	0.25M	0.47M	0.64M	0.57M
Net tangible assets	-	-	-	19.33M	26.13M
Short term investments	-	0.00000M	0.15M	0.29M	0.75M
Net receivables	0.34M	0.23M	0.61M	0.28M	0.92M
Long term debt	4.68M	2.55M	11.73M	7.14M	3.06M
Inventory	1.50M	2.31M	2.13M	2.28M	1.25M
Accounts payable	-	-	-	7.73M	9.11M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	-	-
Deferred long term asset charges	-	-	-	-	-
Non current assets total	15.96M	18.96M	21.10M	26.76M	31.51M
Capital lease obligations	0.00000M	0.04M	0.31M	1.21M	1.32M
Long term debt total	-	-	-	-	-

Breakdown	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Investments	0.00000M	0.18M	-0.72549M	0.23M	-0.13804M
Change to liabilities	-	-	-	-4.47294M	9.78M
Total cashflows from investing activities	-	-	-	-1.65708M	-5.57182M
Net borrowings	0.47M	4.63M	-	4.61M	2.89M
Total cash from financing activities	2.02M	4.63M	5.30M	18.21M	23.32M
Change to operating activities	-	-	-	0.19M	0.24M
Net income	-9.14148M	-16.29763M	-14.51635M	-26.62969M	-43.75581M
Change in cash	0.09M	-0.12986M	-5.13729M	-3.52134M	-4.81358M
Begin period cash flow	0.06M	0.17M	5.34M	8.86M	13.67M
End period cash flow	0.15M	0.06M	0.17M	5.34M	8.86M
Total cash from operating activities	-1.96938M	-5.14977M	-9.70804M	-20.07316M	-22.56421M
Issuance of capital stock	-	-	0.00000M	13.55M	20.36M
Depreciation	1.27M	1.41M	1.58M	1.26M	1.04M
Other cashflows from investing activities	-	-	-	-0.74987M	-0.74987M
Dividends paid	-	-	-	-	-
Change to inventory	0.39M	0.75M	-1.00860M	-3.42282M	-4.71753M
Change to account receivables	-0.13142M	0.42M	-0.39980M	0.13M	-1.98572M
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	-	-	-	-1.28364M	0.04M
Change to netincome	-	-	-	12.88M	16.84M
Capital expenditures	0.00000M	0.02M	0.52M	1.14M	5.43M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	0.79M	2.22M	-1.62328M	-7.57623M	3.31M
Stock based compensation	1.04M	1.54M	2.21M	6.82M	6.48M
Other non cash items	3.49M	2.04M	0.89M	3.76M	1.14M
Free cash flow	-1.96938M	-5.16504M	-10.22991M	-21.21117M	-27.99799M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
PCLO Pharmacielo Ltd	0.005 7.14%	0.07	-	7.18	5.90	9.48	7.71	-6.4975
RX Biosyent Inc.	-0.04 0.28%	14.00	19.10	15.85	3.96	4.11	3.31	11.03
DB Decibel Cannabis Company Inc	- -%	0.12	-	8.67	0.67	1.20	0.99	17.75
ZYUS ZYUS Life Sciences Corporation	- -%	0.50	-	-	108.48	4.41	140.29	-4.258
LSL LSL Pharma Group Inc.	- -%	0.32	20.75	-	1.88	1.89	2.85	10.19

Reports Covered

View All

Profile

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered in Toronto, Canada.

Pharmacielo Ltd

82 Richmond Street East, Toronto, ON, Canada, M5C 1P1

416 315 8741
https://www.pharmacielo.com

Key Executives

Name	Title	Year Born
Mr. William Bill Petron	CEO, Pres & Chairman	NA
Mr. Ian D. Atacan B.Sc., C.M.A., C.P.A., CMA, CPA, M.B.A., MBA	CFO & Director	NA
Mr. Andres Felipe Botero	Chief Operating Officer	NA
Mr. Marcelo Durante	Global Head of Sales & Bus. Devel.	NA
Dr. Decio Rabelo de Castro Filho	Chief Medical Officer	NA
Mr. Alex Bruvels	Corp. Sec.	1988
Mr. Marc Lustig M.B.A., M.Sc.	Chairman & CEO	1974
Mr. Ian D. Atacan B.Sc., C.M.A., C.P.A., M.B.A.	CFO, Corporate Secretary & Director	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.